Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Cartesian Therapeutics, Inc. (RNAC) had Return on Assets of -9.63% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.45M |
|
$-35.90M |
|
-- |
|
$0.45M |
|
$21.52M |
|
$-21.07M |
|
$-14.84M |
|
$-35.90M |
|
$-35.90M |
|
$-35.90M |
|
$-35.90M |
|
$-35.90M |
|
$-35.90M |
|
$-21.07M |
|
$-20.46M |
|
26.00M |
|
26.00M |
|
$-1.38 |
|
$-1.38 |
|
| Balance Sheet Financials | |
$147.26M |
|
$12.39M |
|
$225.41M |
|
$372.68M |
|
$13.80M |
|
-- |
|
$394.72M |
|
$408.52M |
|
$-35.84M |
|
$-84.01M |
|
$-35.84M |
|
26.00M |
|
| Cash Flow Statement Financials | |
$-56.23M |
|
$-4.96M |
|
$-8.00M |
|
$214.28M |
|
$145.12M |
|
$-69.16M |
|
$8.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4660.62% |
|
-4660.62% |
|
-- |
|
-7942.92% |
|
-7942.92% |
|
$-61.19M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.63 |
|
143.76 |
|
100.16% |
|
42.74% |
|
|
Return on Assets |
-9.63% |
100.16% |
|
$-1.38 |
|
$-2.35 |
|
$-2.16 |
|